These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 77846

  • 1. Reaction mechanisms of beta1H globulin.
    Nagaki K, Iida K, Okubo M, Inai S.
    Int Arch Allergy Appl Immunol; 1978; 57(3):221-32. PubMed ID: 77846
    [Abstract] [Full Text] [Related]

  • 2. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2416-20. PubMed ID: 276881
    [Abstract] [Full Text] [Related]

  • 3. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    J Exp Med; 1977 Jul 01; 146(1):257-70. PubMed ID: 301546
    [Abstract] [Full Text] [Related]

  • 4. Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.
    Whaley K, Thompson RA.
    Immunology; 1978 Dec 01; 35(6):1045-9. PubMed ID: 83964
    [Abstract] [Full Text] [Related]

  • 5. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar 01; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 6. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1978 Apr 01; 75(4):1971-5. PubMed ID: 273923
    [Abstract] [Full Text] [Related]

  • 7. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    Fearon DT, Austen KF.
    J Exp Med; 1977 Jul 01; 146(1):22-33. PubMed ID: 559720
    [Abstract] [Full Text] [Related]

  • 8. Interaction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on binding.
    Conrad DH, Carlo JR, Ruddy S.
    J Exp Med; 1978 Jun 01; 147(6):1792-1805. PubMed ID: 567241
    [Abstract] [Full Text] [Related]

  • 9. Structure/function of C5 convertases of complement.
    Rawal N, Pangburn MK.
    Int Immunopharmacol; 2001 Mar 01; 1(3):415-22. PubMed ID: 11367526
    [Abstract] [Full Text] [Related]

  • 10. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 01; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 11. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Schreiber RD, Pangburn MK, Lesavre PH, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1978 Aug 01; 75(8):3948-52. PubMed ID: 279011
    [Abstract] [Full Text] [Related]

  • 12. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N, Pangburn M.
    J Immunol; 2001 Feb 15; 166(4):2635-42. PubMed ID: 11160326
    [Abstract] [Full Text] [Related]

  • 13. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.
    Medof ME, Prince GM, Mold C.
    Proc Natl Acad Sci U S A; 1982 Aug 15; 79(16):5047-51. PubMed ID: 6214790
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.
    Weiler JM, Yurt RW, Fearon DT, Austen KF.
    J Exp Med; 1978 Feb 01; 147(2):409-21. PubMed ID: 624904
    [Abstract] [Full Text] [Related]

  • 15. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
    Fearon DT, Austen KF.
    Proc Natl Acad Sci U S A; 1977 Apr 01; 74(4):1683-7. PubMed ID: 266208
    [Abstract] [Full Text] [Related]

  • 16. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T, Takata Y, Kozono H, Takeda J, Hong KS, Inoue K.
    J Immunol; 1988 Dec 01; 141(11):3895-901. PubMed ID: 3183384
    [Abstract] [Full Text] [Related]

  • 17. The natural modulation of the amplification phase of complement activation.
    Fearon DT, Daha MR, Weiler JM, Austen KF.
    Transplant Rev; 1976 Dec 01; 32():12-25. PubMed ID: 62426
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
    Whaley K, Ward D, Ruddy S.
    Clin Exp Immunol; 1979 Jan 01; 35(1):101-6. PubMed ID: 85507
    [Abstract] [Full Text] [Related]

  • 19. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1076-93. PubMed ID: 978134
    [Abstract] [Full Text] [Related]

  • 20. The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b.
    Fujita T, Nussenzweig V.
    J Exp Med; 1979 Aug 01; 150(2):267-76. PubMed ID: 458376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.